DO-264 (DC11464) chemical structure
Chemical structureResearch use only
CAT. NO. DC11464Featured

DO-264

Pack size & price

USD
Ready-made solution
Total$800
We match the best price and quality on market.
Product overview

Description & Application

DO-264 (DO264) is an ABHD12 inhibitor for lysophosphatidylserine metabolism and immune-lipid signaling research.

ParameterValue
Chemical NameCID 134813646
CAS No.2301866-59-9
SynonymsCID 134813646; 1-(1-(3-Chloro-4-(2-chloro-4-(trifluoromethoxy)phenoxy)pyridin-2-yl)piperidin-4-yl)-3-(pyridin-3-yl)thiourea; 1-[1-[3-chloro-4-[2-chloro-4-(trifluoromethoxy)phenoxy]pyridin-2-yl]piperidin-4-yl]-3-pyridin-3-ylthiourea; DO 264; GTPL10250; compound 46; DO264; DO-264
FormulaC23H20Cl2F3N5O2S
M.Wt558.403411865234
SMILESClC1=C(C([H])=C([H])N=C1N1C([H])([H])C([H])([H])C([H])(C([H])([H])C1([H])[H])N([H])C(N([H])C1=C([H])N=C([H])C([H])=C1[H])=S)OC1C([H])=C([H])C(=C([H])C=1Cl)OC(F)(F)F
PurityOn request
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
ABHD12 · Literature evidence

Biological Activity

DO-264 (DO264) is an ABHD12 inhibitor for lysophosphatidylserine metabolism and immune-lipid signaling research. DO-264 inhibited this lipid hydrolase and increased lyso-PS in primary human macrophages.

In Vitro

EndpointModel / conditions / sourceReported result
Target functionABHD12-dependent lysophosphatidylserine metabolism. [1]DO-264 inhibited this lipid hydrolase and increased lyso-PS in primary human macrophages.

In Vivo

EndpointModel / conditions / sourceReported result
Brain pharmacodynamicsAdult mice treated with DO-264. [1]Brain lyso-PS increased, supporting in-vivo inhibition of ABHD12.
Auditory phenotypePharmacological treatment compared with genetic ABHD12 deletion. [1]Adult drug-treated mice showed minimal auditory disturbance, unlike the knockout phenotype.
Inflammatory limitationImmune-challenge experiments. [1]ABHD12 inhibition was associated with heightened inflammation and severe lung pathology. These results preclude describing the compound as generally innocuous.

Interpretation

Pharmacological inhibition does not reproduce every phenotype of genetic deletion; immune and neurological effects require separate evaluation.

Original studies

References

  1. Ogasawara D, et al. Selective blockade of the lyso-PS lipase ABHD12 stimulates immune responses in vivo. Nature chemical biology (2018).

Product documentation

Refer to the certificate supplied with your lot for batch-specific release results.

Handling guide

2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

For additional quantities or product documentation, contact info@dcchemicals.com.

Related research products

JTE-013 chemical structureDC10607

JTE-013

JTE-013 is an S1PR2 antagonist used in sphingosine-1-phosphate signaling, mitochondrial dynamics and fibrosis research.

View activity & prices
RGX-104 chemical structureDC10719

RGX-104

RGX-104 is an LXR agonist for studying myeloid-derived suppressor cells, ApoE signaling and tumor immune responses.

View activity & prices
TAK-615 chemical structureDC10923

TAK-615

TAK-615 is an LPA1 negative allosteric modulator for receptor signaling and fibrosis-related pathway research.

View activity & prices

Cart

Request quotation